Botanical species · safety record

Orthosiphon aristatus

The EFSA Compendium of Botanicals holds 1 constituent measurement and 3 adverse-effect records for Orthosiphon aristatus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Orthosiphon aristatus (Blume) Miq.

1Constituent measurements

3Safety records

1Cited sources

26Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 26 licensed products naming Orthosiphon aristatus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Flowering top(s)
Grass(es)
Herb
Herb top
Herba
Leaf
Leaf and stem

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Proanthocyanidins (condensed tannins)	Live plants	Solvent extraction	134.6 Milligram/gram	Phytochemical screening	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Live plants	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive: pancreas	Live plants	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive: pancreas	Live plants	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Adisakwattana, Sirichai., Jiphimai, Pariwat., Prutanopajai, Pornsawan., Chanathong, Benjanut., Sapwarobol, Suwimol., Ariyapitipan, Tipayanate. Evaluation of alpha-glucosidase, alpha-amylase and protein glycation inhibitory activities of edible plants. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2010, vol. 61, no. 3, p. 295-305. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature